AdaptHealth Corp (AHCO) Q3 2024 Earnings Call Highlights: Navigating Growth and Challenges [Yahoo! Finance]
AdaptHealth Corp. - Class A (AHCO)
Company Research
Source: Yahoo! Finance
Diabetes Revenue: $141.1 million, decreased 11.8% year-over-year. Respiratory Revenue: $164 million, increased 8.6% year-over-year. Adjusted EBITDA: $164.3 million, with a margin of 20.4%. Free Cash Flow: $84.8 million, outperforming the target of $30 million. Net Leverage Ratio: 2.87 times, down from 3.51 times in Q3 2023. Cash Flow from Operations: $144.4 million. CapEx: $59.6 million, representing 7.4% of revenue. Days Sales Outstanding: 47.9, down from 48.9 in the previous quarter. Full-Year Revenue Guidance: Adjusted to $3.22 billion to $3.26 billion. Full-Year Adjusted EBITDA Guidance: Adjusted to $655 million to $675 million. Full-Year Free Cash Flow Guidance: $175 million to $195 million. Warning! GuruFocus has detected 3 Warning Sign with AHCO. Release Date: November 05, 2024 For the complete transcript of the earnings call, please refer to the full earnings call transcript AdaptHealth Corp ( NASDAQ:AHCO ) reported consistent quarterly results wit
Show less
Read more
Impact Snapshot
Event Time:
AHCO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AHCO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AHCO alerts
High impacting AdaptHealth Corp. - Class A news events
Weekly update
A roundup of the hottest topics
AHCO
News
- AdaptHealth Corp. (NASDAQ: AHCO) had its price target lowered by analysts at Royal Bank of Canada from $13.00 to $11.00. They now have an "outperform" rating on the stock.MarketBeat
- AdaptHealth Corp. (NASDAQ: AHCO) had its price target lowered by analysts at Truist Financial Co. from $13.00 to $12.00. They now have a "buy" rating on the stock.MarketBeat
- AdaptHealth Corp. to Participate in the Stifel 2024 Healthcare ConferenceBusiness Wire
- AdaptHealth Corp. (NASDAQ: AHCO) had its price target lowered by analysts at UBS Group AG from $13.00 to $12.00. They now have a "buy" rating on the stock.MarketBeat
- AdaptHealth Corp. (NASDAQ: AHCO) had its price target lowered by analysts at Canaccord Genuity Group Inc. from $14.00 to $13.00. They now have a "buy" rating on the stock.MarketBeat
AHCO
Earnings
- 11/5/24 - Miss
AHCO
Sec Filings
- 11/15/24 - Form 4
- 11/14/24 - Form SC
- 11/13/24 - Form SC
- AHCO's page on the SEC website